Works matching IS 10531807 AND DT 1999 AND VI 9 AND IP 2


Results: 33
    1
    2
    3
    4
    5
    6
    7
    8
    9

    A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: results of a Phase III clinical trial.

    Published in:
    1999
    By:
    • Rubin, Daniel L.;
    • Desser, Terry S.;
    • Semelka, Richard;
    • Brown, Jeffrey;
    • Nghiem, Hanh V.;
    • Stevens, W. Ross;
    • Bluemke, David;
    • Nelson, Rendon;
    • Fultz, Patrick;
    • Reimer, Peter;
    • Ho, Vincent;
    • Kristy, Rita M.;
    • Pierro, Joseph A.;
    • Rubin, D L;
    • Desser, T S;
    • Semelka, R;
    • Brown, J;
    • Nghiem, H V;
    • Stevens, W R;
    • Bluemke, D
    Publication type:
    journal article
    10
    11

    Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function.

    Published in:
    1999
    By:
    • Swan, Suzanne K.;
    • Baker, James F.;
    • Free, Richard;
    • Tucker, Richard M.;
    • Barron, Bruce;
    • Barr, Richard;
    • Seltzer, Steve;
    • Gazelle, G. Scott;
    • Maravilla, Kenneth R.;
    • Barr, William;
    • Stevens, Gary R.;
    • Lambrecht, Lawrence J.;
    • Pierro, Joseph A.;
    • Swan, S K;
    • Baker, J F;
    • Free, R;
    • Tucker, R M;
    • Barron, B;
    • Barr, R;
    • Seltzer, S
    Publication type:
    journal article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    JMRI strategy for the 21st century.

    Published in:
    Journal of Magnetic Resonance Imaging, 1999, v. 9, n. 2, p. 155, doi. 10.1002/(SICI)1522-2586(199902)9:2<155::AID-JMRI1>3.0.CO;2-S
    By:
    • Fullerton, Gary D.
    Publication type:
    Article
    30
    31
    32
    33